In sectors where the licence, team and pipeline already exist, acquiring or partnering beats a three-year greenfield build. But a China deal runs through gates a market entry never meets. We take foreign buyers and sellers through them.
From the first look to closing and integration, on the buy-side or sell-side.
Corporate, contracts, IP, employment, data, licences and litigation exposure — surfacing the risks that change price or structure.
Share vs asset deals, cross-border share swaps, earn-outs and holding structures, weighed against tax, FX and approvals.
Merger control, national-security review, foreign-investment filings and foreign-exchange registration — mapped and sequenced.
SPA/EPA, shareholders' and JV agreements, warranties and conditions — negotiated in English and Chinese.
Board and chop control, minority protections, and the governance that makes the investment actually work day-to-day.
Selling or reshoring a China operation is its own regulated process — we run it cleanly on the sell-side too.
An acquisition can run through merger control, national-security review and foreign-exchange steps that a greenfield entry never meets. The door to buying is more open than it was — but the doorway is still narrow, and getting the approvals right is where deals succeed or unwind.
Cross-border share swaps are increasingly workable and the rules are being simplified, but they sit inside the foreign-investment and FX framework. Whether it fits your deal depends on structure, sector and the parties — we assess it early, not late.
Yes. We advise foreign buyers entering by acquisition, and foreign groups divesting or reshoring a China business — including the regulated exit process that a sale involves.
Tell us the target or the sector. We'll flag the approvals, the structure options, and the diligence that matters most.
Scan with WeChat to add Aaron Lv on WeChat Work. More ways to reach us